Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361387 · ClinicalTrials.gov registry record · Phase 4
Use of Focalin for Fatigue in Sarcoidosis
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00361387 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 12 participants.
The verdict
NCT00361387, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months. Sarcoidosis and its treatment can greatly affect your quality of life. Many patients suffer from fatigue (feeling tired), lack of focus and concentration, in ability to organize their daily activities, and memory loss. These commonly reported symptoms often get in the way of everyday life.
Interventions
- DRUG d-methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00361387
The ClinicalTrials.gov registry entry for NCT00361387 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which d-methylphenidate is the first listed.
NCT00361387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00361387 about?
NCT00361387 is a clinical study titled "Use of Focalin for Fatigue in Sarcoidosis". Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months. Sarcoidosis and its treatment can greatly affect your quality of life. Many patients suffer from fatigue (feeling tired), lack of focus and concentration, in ability to organize their daily activities, and memory loss. ...
What is the current status of trial NCT00361387?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2006-06. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00361387?
The interventions under investigation include: d-methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00361387?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.